UNIVERSITY CLINIC FOR NEUROSURGERY

Working group DUMITRU

Forschung Dumitru 

Projects

Glioblastoma (GBM) is one of the deadliest types of cancer. It can occur in both adults and children. Despite aggressive therapeutic approaches, 95% of GBM patients die within 5 years after diagnosis.

Our studies aim to characterize the molecular mechanisms involved in GBM pathophysiology, in particular the mechanisms controlling tumor cell proliferation, invasion and resistance to therapy. To this end, we use a multilateral experimental design consisting of in vitro molecular and functional studies, in vivo studies on murine models and in situ analysis of tissue from GBM patients.

Furthermore, we conduct prospective (NeuroCAM) and retrospective (NeuroBIOM) studies on biomaterials from GBM patients in order to identify novel Biomarkers with improved prognostic and predictive accuracy in this type of cancer.

Group Members

Principal Investigator

 

  

Cooperation Partners

  • Prof. Meliha Karsak, ZMNH, University Medical Center Hamburg-Eppendorf
  • Prof. Christian Mawrin, Institute for Neuropathology, University Hospital Magdeburg

 

Last Modification: 23.11.2023 - Contact Person:

Sie können eine Nachricht versenden an: Webmaster
Sicherheitsabfrage:
Captcha
 
Lösung: